Fielmann Group AG (FLMNF)
OTCMKTS · Delayed Price · Currency is USD
61.84
0.00 (0.00%)
Sep 10, 2025, 8:00 PM EDT
Fielmann Group AG Revenue
Fielmann Group AG had revenue of 622.92M EUR in the quarter ending June 30, 2025, with 12.70% growth. This brings the company's revenue in the last twelve months to 2.40B, up 15.32% year-over-year. In the year 2024, Fielmann Group AG had annual revenue of 2.26B with 14.88% growth.
Revenue (ttm)
2.40B EUR
Revenue Growth
+15.32%
P/S Ratio
1.93
Revenue / Employee
98.50K EUR
Employees
24,363
Market Cap
5.42B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.26B | 293.22M | 14.88% |
| Dec 31, 2023 | 1.97B | 211.85M | 12.04% |
| Dec 31, 2022 | 1.76B | 80.90M | 4.82% |
| Dec 31, 2021 | 1.68B | 249.22M | 17.44% |
| Dec 31, 2020 | 1.43B | -91.81M | -6.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 105.45M |
| Tian'an Technology Group | 2.12M |
| Glass House Brands | 221.55M |
| Northwest Biotherapeutics | 1.09M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| Global Cord Blood | 196.10M |
Fielmann Group AG News
- 3 months ago - Fielmann: Margin Recovery Likely, But Still Not Priced In - Seeking Alpha